Latest amyloid plaque News

Lady Gaga says she took lithium after a ‘psychotic break’ – here’s what the science says about this drug
Type 1 diabetes linked to higher dementia risk – new study
Researchers connect the dots between cause-effect events in Alzheimer’s disease
Your morning coffee might protect your brain as you age – here’s the sweet spot
How our lab is helping develop an Alzheimer’s test that can be done at home
People who survive cancers are less likely to develop Alzheimer’s – this might be why
Weight-loss drug doesn’t reduce risk of Alzheimer’s – new studies
Brain “stars” hold the power to preserve cognitive function in model of Alzheimer’s disease
Even a few thousand steps a day can reduce your risk of Alzheimer’s – new study
New blood test could streamline Alzheimer’s diagnosis and treatment access
A new amyloid-lowering therapy is now available for people living with early Alzheimer’s disease with the TGA registration of LEQEMBI (lecanemab)
Ceretas awarded $2.4 million Government Grant for breakthrough Alzheimer’s therapy
Poor sleep may nudge the brain toward dementia, researchers find
Alzheimer’s disease: new three-minute test can spot memory issues – here’s how it works and what it can tell you
Alzheimer’s disease: lithium may help slow cognitive decline – new research in mice
The ‘Mind’ diet is good for cognitive health – here’s what foods you should put on your plate
Drug approval promising step for people with early Alzheimer’s disease
Study reveals impacts of Alzheimer’s disease on the whole body
Alzheimer’s: certain combinations of prescription drugs may slow progression of the disease, says mice study
Early-onset Alzheimer’s: new drug shows promise in slowing the disease
New study reveals link between head injuries and viruses in Alzheimer’s Disease
Microglia digest large Alzheimer’s plaques by spitting enzymes at them
Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows
Grant to help develop portable PET scanner for Alzheimer’s
Alzheimer’s treatment donanemab is not a ‘miracle drug’ – not providing it on the NHS is the right choice
Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why
DEA could reclassify marijuana to a less restrictive category – a drug policy expert weighs the pros and cons
Drug approved in the UK provides first step towards treating Alzheimer’s disease
Prize-winning images showcase the beauty of medical research
Alzheimer’s Disease: It’s Not Only Neurons
Nasal spray clears proteins linked to Alzheimer’s – new study
Alzheimer’s Discovery Holds Potential To Improve Drugs
Alzheimer’s risk higher if your mother had cognitive problems
How your vision can predict dementia 12 years before it is diagnosed – new study
Ultrasound therapy shows promise as a treatment for Alzheimer’s disease
New studies suggest millions with mild cognitive impairment go undiagnosed, often until it’s too late
Research discovers key cause of restricted blood flow to the brain in vascular dementia
Promising results of new Alzheimer’s drug published – early diagnosis is key
New drug slowing Alzheimer’s disease progression approved in U.S
Researchers Find That Brains with More Vitamin D Function Better
Does picking your nose really increase your risk of dementia?
Viral role in Alzheimer’s Disease discovered
Quantifying Cognitive Decline in Dogs Could Help Humans With Alzheimer’s Disease
Signaling pathway in immune cells could be Alzheimer’s target
Twins Study Indicates Environmental Factors Significant in Alzheimer’s Pathology
Early accumulation of tau in brain predicts memory decline in Alzheimer’s disease
Genetic differences important for Alzheimer’s diagnosis
Found: a genetic link to molecular events that precede symptoms in Alzheimer’s disease